Company Filing History:
Years Active: 2013-2014
Title: The Innovative Contributions of Stephanie Hennen
Introduction
Stephanie Hennen is a notable inventor based in Saarburg, Germany. She has made significant contributions to the field of biological research, particularly in the study of GPR17. With a total of 2 patents to her name, her work has implications for understanding and modifying biological activities.
Latest Patents
Hennen's latest patents include innovative methods related to GPR17. The first patent, titled "GPR 17 agonists and screening assay," describes a method for determining a test compound's ability to modify the biological activity of GPR17. This method involves contacting the test compound with GPR17 or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I. The second patent, "Methods of identifying modulators of GPR17," similarly focuses on the ability of test compounds to influence GPR17 activity through comparable methodologies.
Career Highlights
Throughout her career, Stephanie Hennen has worked at prestigious institutions, including Rheinische Friedrich-Wilhelms-Universität Bonn. Her research has contributed to advancements in understanding GPR17 and its potential applications in various biological contexts.
Collaborations
Hennen has collaborated with esteemed colleagues such as Evi Kostenis and Andreas Spinrath, further enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Stephanie Hennen's innovative work in the field of GPR17 research exemplifies her dedication to advancing scientific knowledge. Her patents reflect her commitment to exploring new methodologies that could lead to significant breakthroughs in biological research.